|
JP2000143523A
|
|
Resistance overcoming agent chloroquine-resistant malaria protozoan and antimalarial composition
|
|
JP2000080039A
|
|
Preventive and therapeutic agent for infectious disease with enterohemorrhagic e. coli
|
|
JPH11180873A
|
|
Nf-kappa b activity inhibitor
|
|
JPH09227565A
|
|
Wound healing agent
|
|
JPH08301761A
|
|
Agent for treatment and prevention of intestinal disease
|
|
JPH08301778A
|
|
Agent for treating and preventing intestinal disease
|
|
JPH06211661A
|
|
Antiinflammatory agent
|
|
JPH04108731A
|
|
Anti-aids viral agent
|
|
JPH0499723A
|
|
Virus-genomic inactivator
|
|
JPH0499722A
|
|
Virus-genomic inactivator
|
|
JPH0368557A
|
|
Bisbenzylisoquinoline derivative
|
|
JPH0368578A
|
|
Bisbenzylisoquinoline derivative
|
|
JPH032183A
|
|
Bisbenzylisoquinoline derivative
|
|
JPH02145573A
|
|
Bisbenzylisoquinoline derivative
|
|
JPH02134382A
|
|
Bisbenzylisoquinoline derivative
|
|
JPH02111777A
|
|
Bisbenzylisoquinoline derivative
|
|
JPH01233221A
|
|
Anticancer agent
|
|
JPH01233220A
|
|
Tumor necrotic factor production inductor
|
|
JPH01143833A
|
|
Anti-cancer drug
|
|
JPS63208519A
|
|
Carcinogenic promoting substance inhibitor
|
